Dr Karthik Ramasamy is a Consultant Haematologist at Oxford University Hospitals NHS Trust, Oxford, UK. Dr Ramasamy is the Director of the Oxford Myeloma Translational Research Centre. He is also Lead Clinician for myeloma and other plasma cell dyscrasias at the Thames Valley Strategic Clinical Network, UK. He is the Divisional Lead for Cancer research for National Institute for Health Research, Clinical Research Network Thames Valley and South Midlands, UK. He is an executive member of the UK Myeloma Forum and is an active member of UK Myeloma Research Alliance.
Dr Ramasamy completed his internal medicine training at Nottingham, UK, and subsequently started his haematology training at Glasgow, UK. He completed a comprehensive registrar-training programme encompassing all subspecialties of haematology, including bone marrow transplantation, at King’s College London, London, UK. Following this, he completed three years as a clinical research fellow working on bone marrow microenvironment in myeloma at King’s College London.
Dr Ramasamy has been a Chief Investigator of myeloma studies in renal impairment and bone disease and Principal Investigator on several myeloma trials. Dr Ramasamy’s translational research interests are therapeutic manipulation of marrow microenvironment, myeloma bone disease and myeloma drug resistance mechanisms.